Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Editorial

Peripheral arterial disease in polymyalgia rheumatica

Frances A Borg and Bhaskar Dasgupta*

Author Affiliations

Department of Rheumatology, Southend University Hospital, Prittlewell Chase, Westcliffe-on-Sea, Essex SS0 0RY, UK

For all author emails, please log on.

Arthritis Research & Therapy 2009, 11:111  doi:10.1186/ar2685


See related research article by Warrington et al., http://arthritis-research.com/content/11/2/R50

Published: 20 May 2009

Abstract

Patients with polymyalgia rheumatica have been shown to have an increased risk of peripheral arterial disease on longitudinal follow-up. Possible explanations for this include premature atherosclerosis related to chronic inflammation, as with other inflammatory rheumatological conditions. Alternatively, polymyalgia rheumatica can be associated with vasculitis, even in the absence of clinical giant cell arteritis, and peripheral vascular disease may represent subclinical vasculitis. Further work is required to elucidate the reasons for this increased risk. Currently, it would remain reasonable to aggressively control modifiable atherosclerotic risk factors.